Related Experiment Video
Updated: Jun 11, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Coronary microvascular dysfunction and inflammation: Insights from the Coronary Microvascular Disease Registry
Ilan Merdler1, Kalyan R Chitturi1, Abhishek Chaturvedi1
1Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America.
Insights
Coronary microvascular dysfunction (CMD) was not found to be associated with common inflammation markers like NLR, EMR, or MHR in patients with angina. This study indicates no significant link between these CBC-based inflammatory markers and CMD.
Area of Science:
- Cardiology
- Inflammation Research
- Hematology
Background:
- Coronary microvascular dysfunction (CMD) is linked to inflammatory conditions and endothelial dysfunction.
- Investigating simple inflammatory markers from complete blood count (CBC) analysis is crucial for understanding CMD.
- This study explores the relationship between CMD and common CBC-derived inflammatory markers.
Purpose of the Study:
- To investigate the association between coronary microvascular dysfunction (CMD) and inflammation.
- To evaluate common inflammatory markers, including neutrophil-to-lymphocyte ratio (NLR), eosinophil-to-monocyte ratio (EMR), and monocyte-to-high-density lipoprotein ratio (MHR), in patients with CMD.
- To determine if these CBC-based biomarkers correlate with CMD in patients presenting with angina and non-obstructive coronary arteries.
Main Methods:
- Data from the Coronary Microvascular Disease Registry was analyzed.
- The study included patients with angina and non-obstructive coronary arteries who underwent invasive physiological assessments for CMD.
- Neutrophil-to-lymphocyte ratio (NLR), eosinophil-to-monocyte ratio (EMR), and monocyte-to-high-density lipoprotein ratio (MHR) were examined in 171 patients (126 CMD-negative, 45 CMD-positive).
Main Results:
- No significant differences in baseline characteristics, cardiovascular risk factors, or anti-inflammatory medications were observed between CMD-positive and CMD-negative groups.
- Statistically, there were no significant differences in NLR (p=0.97), EMR (p=0.31), or MHR (p=0.54) between the two groups.
- The findings suggest a lack of correlation between these specific CBC-based inflammatory markers and the presence of CMD.
Conclusions:
- The study found no significant association between coronary microvascular dysfunction (CMD) and simple CBC-based inflammatory biomarkers.
- These findings do not support the use of NLR, EMR, or MHR as indicators of inflammation in patients with CMD.
- Further research may be needed to explore other inflammatory pathways or markers related to CMD.
Background:
Coronary microvascular dysfunction (CMD) is associated with various inflammatory conditions that worsen endothelial dysfunction. This study aimed to investigate the relationship between CMD and inflammation using common inflammatory markers derived from complete blood count (CBC) analysis.
Methods:
Information was gathered from the Coronary Microvascular Disease Registry to examine the neutrophil-to-lymphocyte ratio (NLR), eosinophil-to-monocyte ratio (EMR), and monocyte-to-high-density lipoprotein ratio (MHR) in a cohort of patients with angina who showed non-obstructive coronary arteries and underwent invasive physiological assessments for CMD.
Results:
Of the 171 patients studied, 126 were CMD-negative and 45 were CMD-positive, constituting two groups of interest. The average age of all patients was 61.7 ± 11.1 years, and 63.7 % were female. No significant differences were observed between the two groups in terms of baseline characteristics, cardiovascular risk factors, or potential anti-inflammatory medications. Furthermore, there were no statistically significant differences in NLR (2.54 ± 3.71 vs. 2.52 ± 2.28, p = 0.97), EMR (0.3 ± 0.21 vs. 0.34 ± 0.29, p = 0.31), or MHR (0.02 ± 0.01 vs. 0.01 ± 0.01, p = 0.54) between CMD-positive and CMD-negative patients.
Conclusion:
Our findings did not show a noteworthy connection between CMD and inflammation, as suggested by various simple CBC-based biomarkers.
More Related Videos
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
Related Concept Videos
Assessment of the Cardiovascular System II: Inspection
Head and Neck
Mitral Stenosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetic Retinopathy